These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intravitreal triamcinolone acetonide concentration after subtenon injection. Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide and central serous chorioretinopathy. Jonas JB; Kamppeter BA Br J Ophthalmol; 2005 Mar; 89(3):386-7. PubMed ID: 15722324 [No Abstract] [Full Text] [Related]
8. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840 [TBL] [Abstract][Full Text] [Related]
9. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation. Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M Retina; 2007; 27(9):1201-4. PubMed ID: 18046225 [TBL] [Abstract][Full Text] [Related]
10. Quantification of sedimented triamcinolone for intravitreal injection. Tsong JW; Persaud TO; Mansour SE Retina; 2007; 27(9):1255-9. PubMed ID: 18046234 [TBL] [Abstract][Full Text] [Related]
11. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection. Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363 [TBL] [Abstract][Full Text] [Related]
12. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867 [TBL] [Abstract][Full Text] [Related]
13. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis]. Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial. Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423 [TBL] [Abstract][Full Text] [Related]
15. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye. Kamppeter BA; Cej A; Jonas JB Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920 [TBL] [Abstract][Full Text] [Related]
16. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes. Yi NY; Davis JL; Salmon JH; Gilger BC Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265 [TBL] [Abstract][Full Text] [Related]
18. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models. Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254 [TBL] [Abstract][Full Text] [Related]